Management ChangeJun 1, 2026, 08:18 AM
NuCana Appoints Ian Webster as Chief Financial Officer
AI Summary
NuCana plc announced the appointment of Ian Webster as Chief Financial Officer, effective June 1, 2026. Mr. Webster has served as Interim Chief Financial Officer since June 2025 and was previously Director of Finance since joining the company in 2019. He will continue to serve as the Principal Financial Officer and Principal Accounting Officer, leveraging his over 20 years of finance experience to shape the company's financial strategy. NuCana also highlighted plans to generate data in 2026 from its Phase 2 NuTide:701 study and noted its cash runway is anticipated to extend into 2029.
Key Highlights
- NuCana appointed Ian Webster as Chief Financial Officer, effective June 1, 2026.
- Mr. Webster previously served as Interim Chief Financial Officer since June 2025.
- He joined NuCana in 2019 as Director of Finance.
- Mr. Webster will continue as Principal Financial Officer and Principal Accounting Officer.
- He brings over 20 years of finance experience, including more than a decade in biopharmaceutical senior leadership.
- The company anticipates generating data in 2026 from the Phase 2 NuTide:701 study for NUC-7738.
- NuCana's cash runway is anticipated to extend into 2029.
Price Impact
More from NCNA